Lianhai Zhang

Mount Sinai Hospital — Canada

Medicine · Health Sciences

38h-index4.8kcitations216works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(66), RNA modifications and cancer(34), Cancer-related molecular mechanisms research(33), Metastasis and carcinoma case studies(29), Epigenetics and DNA Methylation(27)

Publications216 total

LIMB-SALVAGE SURGERY AFTER UNPLANNED SURGERY FOR EXTREMITY BONE SARCOMAS: 30-YEAR EXPERIENCE AT A TERTIARY REFERRAL CENTRE
Orthopaedic Proceedings·2025
THE UTILITY OF INTRAOPERATIVE MARROW MARGIN FROZEN SECTION IN EXTREMITY BONE SARCOMA RESECTION
Orthopaedic Proceedings·2025
[Development and dissemination of precision medicine approaches in gastric cancer management].
PubMed·2025
EP.14.20 Whole-Exome Sequencing Study of Thymic Epithelial Tumors
Journal of Thoracic Oncology·2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
The Lancet Oncology·2025· 32 cited
43P Efficacy and safety of paclitaxel liposomes in combination with anti-HER-2 targeted drugs as first-line rescue therapy for HER-2-positive locally advanced or metastatic breast cancer: A retrospective, real-world study based on the Cancer Database of China National Cancer Center (NCC)
Annals of Oncology·2024Open Access
CDKN2A somatic copy number amplification in normal tissues surrounding gastric carcinoma reduces cancer metastasis risk in droplet digital PCR analysis
Gastric Cancer·2024· 3 citedOpen Access
Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer Cells by Reducing EMT Signaling
Anticancer Research·2023· 9 cited
IDDF2023-ABS-0250 Comprehensive analyses of microbiome and metabolism reveal liver metastasis-specific signature in colorectal cancer
2023· 1 cited
Anti-PD1 antibody pucotenlimab in combination with bevacizumab or lenvatinib in a phase II study for the treatment of advanced hepatocellular carcinoma (aHCC).
Journal of Clinical Oncology·2023
High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
npj Precision Oncology·2023· 14 citedOpen Access
Supplementary Tables S1-S6 and Supplementary Figures S1-S2 from BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers
2023Open Access
Data from BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers
2023Open Access
Data from BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers
2023Open Access
Supplementary Tables S1-S6 and Supplementary Figures S1-S2 from BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers
2023Open Access
Data Supplement from Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
2023Open Access
Data from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing lncRNA DUSP5P1 and Associates with Patient Outcomes
2023Open Access
Data Supplement from Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
2023Open Access
Data Supplement from Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
2023Open Access
Data from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing lncRNA DUSP5P1 and Associates with Patient Outcomes
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Jiafu Ji(45), Ziyu Li(25), Zhaode Bu(19), Xiaojiang Wu(16), Aiwen Wu(14), Ying Hu(11), Fei Shan(11), Hong Du(11), Shuangxi Li(10), Yiqiang Liu(9), Xiaojing Cheng(9), Xiaohong Wang(9), Xiaofang Xing(8), Xianglong Zong(7), Yongning Jia(6), Bin Dong(6), Zhongwu Li(5), Xianzi Wen(5), Xin Ji(5), Jiyou Li(5)